Precision Medicine, Gene Therapy, and Pharmacogenomics

DOI 10.66715/cerebral/2026.pmgtphar | Cerebral Publication Private Limited | CIN: U58111DL2025PTC459104 | 2026 | Volume 1 | Issue 2 | Page 1-300 | ISBN: 978-81-689463-0-9 | Book Title: - Textbook of Clinical Genetics | Chapter-9: Precision Medicine, Gene Therapy, and Pharmacogenomics

Author: Dr. Abhilash Sahoo, MBBS (Hons), MD Paediatrics, Department of Paediatrics, SRTR GMC, Ambajogai

Abstract

Precision medicine, gene therapy, and pharmacogenomics represent transformative advances in modern healthcare, enabling disease prevention, diagnosis, and treatment to be tailored according to an individual's genetic, molecular, environmental, and lifestyle characteristics. Unlike the traditional "one-size-fits-all" approach, precision medicine integrates genomic, transcriptomic, proteomic, metabolomic, and clinical data to optimize patient care and improve therapeutic outcomes. Rapid progress in molecular genetics, next-generation sequencing (NGS), bioinformatics, and artificial intelligence has accelerated the identification of disease-associated genetic variants and therapeutic targets, fostering the development of personalized treatment strategies across multiple medical specialties.

This chapter explores the principles and clinical applications of precision medicine, highlighting its role in oncology, cardiology, neurology, infectious diseases, rare genetic disorders, and chronic non-communicable diseases. It discusses the fundamentals of pharmacogenomics, including the influence of genetic variation on drug metabolism, efficacy, toxicity, and adverse drug reactions, with emphasis on clinically relevant pharmacogenes such as CYP450, TPMT, DPYD, SLCO1B1, and HLA alleles. The chapter also reviews current approaches to gene therapy, including viral and non-viral gene delivery systems, gene replacement therapy, RNA-based therapeutics, genome editing technologies such as CRISPR-Cas systems, base editing, and prime editing, as well as emerging cell-based therapies for inherited and acquired diseases.

Additionally, the chapter addresses the challenges associated with implementing precision medicine, including genomic data interpretation, healthcare infrastructure, regulatory frameworks, ethical and legal considerations, patient privacy, equitable access, and cost-effectiveness. The integration of multi-omics technologies, digital health platforms, machine learning, and real-world clinical data is presented as a key driver of future innovations in personalized healthcare.

A comprehensive understanding of precision medicine, gene therapy, and pharmacogenomics equips healthcare professionals, researchers, pharmacists, and students with the knowledge required to translate genomic discoveries into clinical practice. These rapidly evolving fields are reshaping medical care by enabling individualized prevention, targeted therapies, optimized drug selection, and improved patient outcomes, thereby advancing the future of evidence-based and precision healthcare.